RxSight, Inc. (RXST)
NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 59.10 |
| Open | 59.69 |
| Bid | 60.07 x 100 |
| Ask | 60.30 x 500 |
| Day's range | 58.99 - 60.81 |
| 52-week range | 20.66 - 66.54 |
| Volume | |
| Avg. volume | 426,471 |
| Market cap | 2.362B |
| Beta (5Y monthly) | 1.22 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Institutional investors control 71% of RxSight, Inc. (NASDAQ:RXST) and were rewarded last week after stock increased 6.0%
Key Insights Institutions' substantial holdings in RxSight implies that they have significant influence over the...
- GuruFocus.com
Insider Sale: Director Julie Andrews Sells 15,625 Shares of RxSight Inc (RXST)
On June 14, 2024, Julie Andrews, Director at RxSight Inc (NASDAQ:RXST), executed a sale of 15,625 shares of the company at a price of $58 per share.
- Investor's Business Daily
Eye Care Innovator In Buy Zone; 176% Growth Expected For IBD 50 Stock
This cataract lens stock has gained 44% this year and over 200% since 2023. Analysts expect the company to turn profitable in 2024.
© 2024 Yahoo. All rights reserved.